Oxidant stress is increased during treatment of human immunodeficiency virus infection.

Hulgan T, Morrow J, D'Aquila RT, Raffanti S, Morgan M, Rebeiro P, Haas DW
Clin Infect Dis. 2003 37 (12): 1711-7

PMID: 14689356 · DOI:10.1086/379776

MeSH Terms (11)

Adult Anti-HIV Agents Antiretroviral Therapy, Highly Active F2-Isoprostanes Female HIV-1 HIV Infections Humans Male Oxidants Oxidative Stress

Connections (2)

This publication is referenced by other Labnodes entities:

Links